Published in Br J Pharmacol on July 02, 2007
Toxicology. Transforming environmental health protection. Science (2008) 7.50
Quantifying biogenic bias in screening libraries. Nat Chem Biol (2009) 1.66
Phenotypic screens as a renewed approach for drug discovery. Drug Discov Today (2013) 1.18
Identification of compounds that potentiate CREB signaling as possible enhancers of long-term memory. Proc Natl Acad Sci U S A (2009) 1.13
No time to lose--high throughput screening to assess nanomaterial safety. Nanoscale (2011) 1.11
Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes. Cancer Res (2014) 1.11
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries. Bioorg Med Chem (2009) 1.02
Plate reader-based assays for measuring cell viability, neuroprotection and calcium in primary neuronal cultures. J Neurosci Methods (2011) 0.95
Human synthetic lethal inference as potential anti-cancer target gene detection. BMC Syst Biol (2009) 0.92
Matching the power of high throughput screening to the chemical diversity of natural products. Nat Prod Rep (2013) 0.90
Identification of new classes of ricin toxin inhibitors by virtual screening. Toxicon (2010) 0.90
Translational research in infectious disease: current paradigms and challenges ahead. Transl Res (2012) 0.83
Machine-learning techniques applied to antibacterial drug discovery. Chem Biol Drug Des (2015) 0.81
Structural models in the assessment of protein druggability based on HTS data. J Comput Aided Mol Des (2009) 0.79
Differential nuclear staining assay for high-throughput screening to identify cytotoxic compounds. Curr Cell Biochem (2011) 0.79
Cloning-independent expression and analysis of omega-transaminases by use of a cell-free protein synthesis system. Appl Environ Microbiol (2010) 0.79
Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studies. Braz J Med Biol Res (2016) 0.78
High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors. PLoS One (2016) 0.77
Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors. Antimicrob Agents Chemother (2016) 0.76
Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files. Mol Divers (2016) 0.75
A Novel Assay for Screening Inhibitors Targeting HIV Integrase LEDGF/p75 Interaction Based on Ni(2+) Coated Magnetic Agarose Beads. Sci Rep (2016) 0.75
Discovery of novel small molecule inhibitors of cardiac hypertrophy using high throughput, high content imaging. J Mol Cell Cardiol (2016) 0.75
An inverse small molecule screen to design a chemically defined medium supporting long-term growth of Drosophila cell lines. Mol Biosyst (2014) 0.75
Biofabricated constructs as tissue models: a short review. J Mater Sci Mater Med (2015) 0.75
Functional homology of mammalian and yeast RAS genes. Cell (1985) 14.01
Genes in S. cerevisiae encoding proteins with domains homologous to the mammalian ras proteins. Cell (1984) 6.87
A potent nonpeptide antagonist of the substance P (NK1) receptor. Science (1991) 4.06
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding. J Pharm Sci (2003) 1.35
Novel miniaturized systems in high-throughput screening. Trends Biotechnol (2002) 1.16
Diversity screening versus focussed screening in drug discovery. Drug Discov Today (2000) 1.12
Impact of nonspecific binding to microsomes and phospholipid on the inhibition of cytochrome P4502D6: implications for relating in vitro inhibition data to in vivo drug interactions. Drug Metab Dispos (2003) 1.08
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesterase. J Med Chem (1998) 0.98
Rest in Drosophila is a sleep-like state. Neuron (2000) 5.72
Hours, volume, and type of work of preregistration house officers. BMJ (1990) 5.68
Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol (1994) 5.66
Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. Br Med J (1978) 4.99
Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg (1993) 4.75
Pattern formation and eyespot determination in butterfly wings. Science (1994) 3.98
Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest (1985) 2.64
Delayed reinforcement as an indiscriminable contingency in verbal/nonverbal correspondence training. J Appl Behav Anal (1984) 2.43
Pancreatic acinar cells: acetylcholine-induced membrane depolarization, calcium efflux and amylase release. J Physiol (1973) 2.12
Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic Biol Med (1994) 2.03
Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science (1986) 2.00
Possible role of microtubules in thyroid secretion. Proc Natl Acad Sci U S A (1970) 2.00
A non-circadian role for cAMP signaling and CREB activity in Drosophila rest homeostasis. Nat Neurosci (2001) 1.95
Liver disease in Crohn's disease. A study of 100 consecutive patients. Scand J Gastroenterol (1971) 1.89
U73122 inhibits Ca2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. J Biol Chem (1992) 1.83
Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini. Am J Physiol (1978) 1.80
The current use of vagotomy in the treatment of peptic ulceration. Br J Surg (1969) 1.79
Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology (1984) 1.79
Evaluation of two commercial systems for identification of coagulase-negative staphylococci to species level. Diagn Microbiol Infect Dis (1994) 1.71
Post-gastrectomy bile vomiting. Lancet (1965) 1.68
Glucocorticoids increase amylase mRNA levels, secretory organelles, and secretion in pancreatic acinar AR42J cells. J Cell Biol (1985) 1.68
HSP27 expression regulates CCK-induced changes of the actin cytoskeleton in CHO-CCK-A cells. Am J Physiol (1999) 1.67
Management of internal haemorrhoids by rubber-band ligation. Br J Surg (1971) 1.65
Response-reinforcer relationships and improved learning in autistic children. J Appl Behav Anal (1981) 1.63
Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection. Infect Immun (1998) 1.63
Direct versus indirect response-reinforcer relationships in teaching autistic children. J Abnorm Child Psychol (1980) 1.62
Identification of a Chlamydia trachomatis serovar E urogenital isolate which lacks the cryptic plasmid. Infect Immun (1998) 1.56
Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res (2000) 1.56
Control of pancreatic amylase release in vitro: effects of ions, cyclic AMP, and colchicine. Br J Pharmacol (1972) 1.56
Outpatient operations. I. The surgeon's view. Br Med J (1969) 1.55
Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations. Clin Pharmacol Ther (2008) 1.53
Cytochalasin B inhibits thyroid secretion. Biochem Biophys Res Commun (1971) 1.53
The effects of diversion of intestinal contents on the progress of Crohn's disease of the large bowel. Gut (1971) 1.53
Resistance plasmids in Pseudomonas cepacia 4G9. J Bacteriol (1979) 1.50
Polydioxanone (PDS), a novel monofilament synthetic absorbable suture. Surg Gynecol Obstet (1981) 1.47
Determination of carbonyl groups in oxidized proteins. Methods Mol Biol (2000) 1.47
Origin of transmembrane potentials in non-excitable cells. J Theor Biol (1970) 1.45
Intracellular free calcium concentrations in isolated pancreatic acini; effects of secretagogues. Biochem Biophys Res Commun (1983) 1.43
The insulin-pancreatic acinar axis. Diabetes (1985) 1.42
Good outcome from surgery for ampullary tumour. Aust N Z J Surg (1999) 1.41
Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. J Biol Chem (1980) 1.41
Colchicine-binding protein and the secretion of thyroid hormone. J Cell Biol (1972) 1.40
Regulation of pancreatic acinar cell function by intracellular calcium. Am J Physiol (1980) 1.40
The fate of ileorectal anastomosis in Crohn's disease. Gut (1971) 1.39
The incidence of recurrence in Crohn's disease. Surg Gynecol Obstet (1972) 1.38
A biologic comparison of polyglactin 910 and polyglycolic acid synthetic absorbable sutures. Surg Gynecol Obstet (1975) 1.38
Intracellular divalent cation release in pancreatic acinar cells during stimulus-secretion coupling. I. Use of chlorotetracycline as fluorescent probe. J Cell Biol (1978) 1.37
Effect of selective and proximal gastric vagotomy on serum gastrin. Gastroenterology (1974) 1.36
Hip fracture outcomes: quality of life and functional status in older adults living in the community. Aust N Z J Med (2000) 1.36
Crohn's disease involving the colon: an audit of clinical management. Gastroenterology (1977) 1.36
Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc Natl Acad Sci U S A (1996) 1.34
Partial gastrectomy: the value of permanent vitamin-B-12 therapy. Lancet (1966) 1.32
Effects of ouabain and diphenylhydantoin on transmembrane potentials, intracellular electrolytes, and cell pH of rat muscle and liver in vivo. J Physiol (1971) 1.32
Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest (1986) 1.31
Pancreatic acinar cells in monolayer culture: direct trophic effects of caerulein in vitro. Am J Physiol (1986) 1.29
Antimalarial dyes revisited: xanthenes, azines, oxazines, and thiazines. Antimicrob Agents Chemother (1995) 1.28
Development of a diurnal resting box to collect Culiseta melanura (COQ.). Am J Trop Med Hyg (1968) 1.28
Luminescence imaging microscopy and lifetime mapping using kinetically stable lanthanide(III) complexes. J Photochem Photobiol B (2000) 1.27
Behavioral contrast and generalization across settings in the treatment of autistic children. J Exp Child Psychol (1980) 1.26
The place of surgery in Crohn's disease. Gut (1971) 1.25
Use of gastric function tests by British gastroenterologists. Br Med J (1971) 1.22
Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat. Am J Physiol (1986) 1.21
Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med (1995) 1.21
Effects of mother-infant separation on maternal attachment behavior. Child Dev (1972) 1.20
Pancreatic acinar cells: effects of lanthanum ions on amylase release and calcium ion fluxes. J Physiol (1974) 1.19
Gastric stasis and gastric ulcer after selective vagotomy without a drainage procedure. Br Med J (1972) 1.19
Determination of extracellular space and intracellular electrolytes in rat liver in vivo. J Physiol (1971) 1.18
Stress kinases and heat shock proteins in the pancreas: possible roles in normal function and disease. J Gastroenterol (2000) 1.17
The role of microtubles and microfilaments in thyroid secretion. Recent Prog Horm Res (1973) 1.17
Pancreatic acinar cells: use of Ca++ ionophore to separate enzyme release from the earlier steps in stimulus-secretion coupling. Biochem Biophys Res Commun (1974) 1.17
Self-focused ZnO transducers for ultrasonic biomicroscopy. J Appl Phys (2008) 1.15
A P element chimera containing captured genomic sequences was recovered at the vestigial locus in Drosophila following targeted transposition. Genetics (1992) 1.15
A single mutation converts a novel phosphotyrosine binding domain into a dual-specificity phosphatase. J Biol Chem (1995) 1.15
Intracellular divalent cation release in pancreatic acinar cells during stimulus-secretion coupling. II. Subcellular localization of the fluorescent probe chlorotetracycline. J Cell Biol (1978) 1.14
A role for the p38 mitogen-activated protein kinase/Hsp 27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini. J Biol Chem (1998) 1.13
Cholecystokinin receptors in the brain: characterization and distribution. Science (1980) 1.13
Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Blood (2000) 1.12
A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer (2000) 1.12
A viable herd of genetically uniform cattle. Nature (2001) 1.12
Potentiation of cholecystokinin-induced exocrine secretion by both exogenous and endogenous insulin in isolated and perfused rat pancreata. J Clin Invest (1980) 1.12
Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Gut (1987) 1.11
Stomach drainage after vagotomy and pyloroplasty. Am J Surg (1967) 1.11
Purification and characterization of a novel physiological substrate for calcineurin in mammalian cells. J Biol Chem (1998) 1.10
Activation of MAP kinase kinase (MEK) and Ras by cholecystokinin in rat pancreatic acini. Am J Physiol (1995) 1.10
Multiple sources of 1,2-diacylglycerol in isolated rat pancreatic acini stimulated by cholecystokinin. Involvement of phosphatidylinositol bisphosphate and phosphatidylcholine hydrolysis. J Biol Chem (1989) 1.09
Overexpression of Rab3D enhances regulated amylase secretion from pancreatic acini of transgenic mice. J Clin Invest (1997) 1.09
Anal dilatation versus rubber band ligation for internal hemorrhoids. Method of treatment in outpatients. Am J Surg (1971) 1.09
Dynamic rearrangement of the spectrin membrane skeleton during the generation of epithelial polarity in Drosophila. J Cell Sci (1999) 1.08
Radiological anatomy after pyloroplasty. Gut (1970) 1.08
Oscillatory mode of calcium signaling in rat pancreatic acinar cells. Am J Physiol (1990) 1.08
Regulation of cholecystokinin secretion by food, hormones, and neural pathways in the rat. Am J Physiol (1990) 1.08
Intercellular calcium waves in rat pancreatic acini: mechanism of transmission. Am J Physiol (1996) 1.08
Regulation of hypothalamic proopiomelanocortin by leptin in lean and obese rats. Neuroendocrinology (1999) 1.07
Na+ dependence of in vitro pancreatic amylase release. Am J Physiol (1975) 1.07
Norethisterone treatment to control timing of the IVF cycle. Hum Reprod (1986) 1.06
Analysis of tissue amylase output by an automated method. Anal Biochem (1974) 1.06
Evaluation of an immunological test for occult bleeding from colorectal neoplasia. Aust N Z J Surg (1982) 1.05
Effects of carbachol, cholecystokinin, and insulin on protein phosphorylation in isolated pancreatic acini. J Biol Chem (1982) 1.05
Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. Circulation (1990) 1.05